コンテンツメニュー

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)

BMC cancer Volume 12 Issue 1 Page 307-
published_at 2012-07-23
Title
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II)
Creators Tsuburaya Akira
Creators Morita Satoshi
Creators Kodera Yasuhiro
Creators Kobayashi Michiya
Creators Shitara Kohei
Creators Yamaguchi Kensei
Creators Yoshikawa Takaki
Creators Yoshida Kazuhiro
Creators Yoshino Shigefumi
Creators Sakamoto Jun-ichi
Creator Keywords
Biomarker Capecitabine Cisplatin Clinical trial Gastric cancer S-1
Languages eng
Resource Type journal article
Publishers BioMed Central
Date Issued 2012-07-23
File Version Not Applicable (or Unknown)
Access Rights metadata only access
Relations
[ISSN]1471-2407
[NCID]AA12034763
[PMID]info:pmid/22824079
info:doi/10.1186/1471-2407-12-307
[isVersionOf] [URI]http://www.biomedcentral.com/bmccancer/archive/
Schools 医学部附属病院